Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Neoplasms of the CNS

Free Subscription 23.04.2018 1 AJNR Am J Neuroradiol 1 BMC Cancer 1 Cancer Res 1 Childs Nerv Syst 1 Curr Treat Options Neurol 1 Eur J Cancer 1 Int J Radiat Oncol Biol Phys 7 J Neurooncol 2 J Neurosurg 5 Neuro Oncol 1 Neuroradiology 6 Neurosurgery 1 Oncogene

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

AJNR Am J Neuroradiol

1. CHEN IE, Swinburne N, Tsankova NM, Hefti MM, et al
   Sequential Apparent Diffusion Coefficient for Assessment of Tumor Progression in Patients with Low-Grade Glioma.
   AJNR Am J Neuroradiol. 2018 Apr 19. pii: ajnr.A5639. doi: 10.3174/ajnr.A5639.
   PubMed     Text format     Abstract available
   
   

   
   BMC Cancer

2. JIN J, Gao Y, Zhang J, Wang L, et al
   Incidence, pattern and prognosis of brain metastases in patients with metastatic triple negative breast cancer.
   BMC Cancer. 2018;18:446.
   PubMed     Text format     Abstract available
   
   

   
   Cancer Res

3. LIU J, Sareddy GR, Zhou M, Viswanadhapalli S, et al
   Differential effects of estrogen receptor beta isoforms on glioblastoma progression.
   Cancer Res. 2018 Apr 16. pii: 0008-5472.CAN-17-3470.
   PubMed     Text format     Abstract available
   
   

   
   Childs Nerv Syst

4. ZOHREH H, Farideh N, Abbas A
   Letter to the editor Management and outcome of treating pediatric medulloblastoma.
   Childs Nerv Syst. 2018 Apr 20. pii: 10.1007/s00381-018-3795.
   PubMed     Text format    
   
   

   
   Curr Treat Options Neurol

5. KURZ SC, Wen PY
   Quo Vadis-Do Immunotherapies Have a Role in Glioblastoma?
   Curr Treat Options Neurol. 2018;20:14.
   PubMed     Text format     Abstract available
   
   

   
   Eur J Cancer

6. WOLPERT F, Weller M, Berghoff AS, Rushing E, et al
   Diagnostic value of (18)F-fluordesoxyglucose positron emission tomography for patients with brain metastasis from unknown primary site.
   Eur J Cancer. 2018;96:64-72.
   PubMed     Text format     Abstract available
   
   

   
   Int J Radiat Oncol Biol Phys

7. SCHAPIRA E, Hubbeling H, Yeap BY, Mehan WA Jr., et al
   Improved Overall Survival and Locoregional Disease Control With Concurrent PD-1 Pathway Inhibitors and Stereotactic Radiosurgery for Lung Cancer Patients With Brain Metastases.
   Int J Radiat Oncol Biol Phys. 2018 Mar 22. pii: S0360-3016(18)30542.
   PubMed     Text format     Abstract available
   
   

   
   J Neurooncol

8. PATEL CB, Fazzari E, Chakhoyan A, Yao J, et al
   (18)F-FDOPA PET and MRI characteristics correlate with degree of malignancy and predict survival in treatment-naive gliomas: a cross-sectional study.
   J Neurooncol. 2018 Apr 20. pii: 10.1007/s11060-018-2877.
   PubMed     Text format     Abstract available
   
   
9. FRANCESCHI E, Lamberti G, Paccapelo A, Di Battista M, et al
   Third-line therapy in recurrent glioblastoma: is it another chance for bevacizumab?
   J Neurooncol. 2018 Apr 18. pii: 10.1007/s11060-018-2873.
   PubMed     Text format     Abstract available
   
   
10. HEMPEL JM, Brendle C, Bender B, Bier G, et al
    Contrast enhancement predicting survival in integrated molecular subtypes of diffuse glioma: an observational cohort study.
    J Neurooncol. 2018 Apr 17. pii: 10.1007/s11060-018-2872.
    PubMed     Text format     Abstract available
    
    
11. GUASTELLA AR, Michelhaugh SK, Klinger NV, Fadel HA, et al
    Investigation of the aryl hydrocarbon receptor and the intrinsic tumoral component of the kynurenine pathway of tryptophan metabolism in primary brain tumors.
    J Neurooncol. 2018 Apr 17. pii: 10.1007/s11060-018-2869.
    PubMed     Text format     Abstract available
    
    
12. JANSSENS GO, Kramm CM, von Bueren AO
    Diffuse intrinsic pontine gliomas (DIPG) at recurrence: is there a window to test new therapies in some patients?
    J Neurooncol. 2018 Apr 17. pii: 10.1007/s11060-018-2871.
    PubMed     Text format    
    
    
13. WIJNENGA MMJ, French PJ, Dubbink HJ, Dinjens WNM, et al
    Prognostic relevance of mutations and copy number alterations assessed with targeted next generation sequencing in IDH mutant grade II glioma.
    J Neurooncol. 2018 Apr 16. pii: 10.1007/s11060-018-2867.
    PubMed     Text format     Abstract available
    
    
14. BARONI M, Marie SKN, Fedatto PF, Andrade AF, et al
    Distinct response to GDF15 knockdown in pediatric and adult glioblastoma cell lines.
    J Neurooncol. 2018 Apr 18. pii: 10.1007/s11060-018-2853.
    PubMed     Text format     Abstract available
    
    

    
    J Neurosurg

15. JHAVERI J, Chowdhary M, Zhang X, Press RH, et al
    Does size matter? Investigating the optimal planning target volume margin for postoperative stereotactic radiosurgery to resected brain metastases.
    J Neurosurg. 2018 Apr 20:1-7. doi: 10.3171/2017.9.JNS171735.
    PubMed     Text format     Abstract available
    
    
16. MORSHED RA, Young JS, Han SJ, Hervey-Jumper SL, et al
    The transcortical equatorial approach for gliomas of the mesial temporal lobe: techniques and functional outcomes.
    J Neurosurg. 2018 Apr 20:1-9. doi: 10.3171/2017.10.JNS172055.
    PubMed     Text format     Abstract available
    
    

    
    Neuro Oncol

17. ELLINGSON BM, Aftab DT, Schwab GM, Hessel C, et al
    Volumetric response quantified using T1 subtraction predicts long-term survival benefit from cabozantinib monotherapy in recurrent glioblastoma.
    Neuro Oncol. 2018 Apr 5. pii: 4962211. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
18. ELLINGSON BM, Abrey LE, Nelson SJ, Kaufmann TJ, et al
    Validation of post-operative residual contrast enhancing tumor volume as an independent prognostic factor for overall survival in newly diagnosed glioblastoma.
    Neuro Oncol. 2018 Apr 5. pii: 4962189. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
19. LINNINGER A, Hartung GA, Liu BP, Mirkov S, et al
    Modeling the diffusion of D-2-hydroxyglutarate from IDH1 mutant gliomas in the central nervous system.
    Neuro Oncol. 2018 Apr 5. pii: 4962158. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
20. KOGA T, Li B, Figueroa JM, Ren B, et al
    Mapping of genomic EGFRvIII deletions in glioblastoma: insight into rearrangement mechanisms and biomarker development.
    Neuro Oncol. 2018 Apr 12. pii: 4969527. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
21. DU Z, Brewster R, Merrill PH, Chmielecki J, et al
    Meningioma transcription factors link cell lineage with systemic metabolic cues.
    Neuro Oncol. 2018 Apr 12. pii: 4969420. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    

    
    Neuroradiology

22. LIU X, Li J, Xu Q, Mantini D, et al
    Pathological factors contributing to crossed cerebellar diaschisis in cerebral gliomas: a study combining perfusion, diffusion, and structural MR imaging.
    Neuroradiology. 2018 Apr 17. pii: 10.1007/s00234-018-2015.
    PubMed     Text format     Abstract available
    
    

    
    Neurosurgery

23. KERR K, Qualmann K, Esquenazi Y, Hagan J, et al
    Familial Syndromes Involving Meningiomas Provide Mechanistic Insight Into Sporadic Disease.
    Neurosurgery. 2018 Apr 11. pii: 4967789. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
24. PATEL P, Wallace D, Boop FA, Vaughn B, et al
    Reoperation for Medulloblastoma Prior to Adjuvant Therapy.
    Neurosurgery. 2018 Apr 11. pii: 4968040. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
25. KHAN MB, Schneider JR, Kwan K, Boockvar JA, et al
    Epigentic Regulators of Glioma Stem Cells are Potential Therapeutic Targets.
    Neurosurgery. 2018;82:E104-E105.
    PubMed     Text format    
    
    
26. ALEXIADES N, McKhann GM 2nd
    A Shock to the System: Tumor-Treating Fields Plus Temozolomide for Glioblastoma.
    Neurosurgery. 2018;82:E115-E116.
    PubMed     Text format    
    
    
27. LUBIN JA, Zhang RR, Kuo JS
    Zika Virus has Oncolytic Activity Against Glioblastoma Stem Cells.
    Neurosurgery. 2018;82:E113-E114.
    PubMed     Text format    
    
    
28. 
    Defining Glioblastoma Resectability Through the Wisdom of the Crowd: A Proof-of-Principle Study.
    Neurosurgery. 2018;82:749.
    PubMed     Text format    
    
    

    
    Oncogene

29. LU J, Liu L, Zheng M, Li X, et al
    MEKK2 and MEKK3 suppress Hedgehog pathway-dependent medulloblastoma by inhibiting GLI1 function.
    Oncogene. 2018 Apr 17. pii: 10.1038/s41388-018-0249.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Neoplasms of the CNS is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: